Intelligent road technology developer Cavnue raised the cash in a series A round co-led by Ford Motor Company while two other strategic partners, Globalvia and Landstar, also invested.

Salesforce Ventures, an investor in the sales generation software developer since seed stage, returned for a round hiking its overall funding to $158m.

Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.

GAC has returned to lead the Tencent and Guangzhou Public Transport-backed automated taxi developer’s latest round, which included WeRide and Pony.ai.

GS Group contributed to a series B round that pushed messenger RNA therapeutics and vaccine developer RVAC Medicines' overall funding to $140m.

HPE, Nvidia, GlobalFoundries, Intel Capital, Applied Ventures and Lockheed Martin Ventures helped push the semiconductor technology provider's total funding past $190m.

Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.

CVS Health joined returning backers that could include SoftBank Vision Fund 2, MassMutual Ventures, Jianke and Aviva in a round valuing the digital care service at $1.3bn.

Migdal and Menora Mivtachim helped supply the renewable energy infrastructure developer with fresh funding which will help expand its operations in the UK and Finland.

ServiceNow, Capital One Ventures, Citi Ventures, Splunk Ventures and GV all contributed to the software deployment technology provider's latest round, valuing it at $3.7bn.